We are live on !
Find out more
Freestone Grove Partners Portfolio holdings
AUM
$15.6B
Turnover
60.27%
1-Year Est. Return
27.39%
This Fund
S&P 500
This Quarter Est. Return
+14.49%
1 Year Est. Return
+27.39%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$15.6B
AUM Growth
+$1.42B
(+10%)
Cap. Flow
+$81.1M
Cap. Flow % of AUM
Cap. Flow %
0.52%
Top 10 Holdings %
Top 10 Hldgs %
22.3%
Holding
1,397
New
435
Increased
253
Reduced
266
Closed
407
Avg Time Held
Equity + Options
0.3
years
Top 10 Avg Time Held
Equity + Options
0.2
years
Top 20 Avg Time Held
Equity + Options
0.1
years
Avg Time Held Equity only
0.3
years
Top 10 Avg Time Held Equity only
0.2
years
Top 20 Avg Time Held Equity only
0.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$311M |
| 2 |
Abbott
ABT
|
+$125M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$121M |
| 4 |
SpaceX
SPCX
|
+$116M |
| 5 |
Procter & Gamble
PG
|
+$111M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Datadog
DDOG
|
+$128M |
| 2 |
Pinnacle Financial Partners Inc
PNFP
|
+$111M |
| 3 |
Elastic
ESTC
|
+$110M |
| 4 |
Twilio
TWLO
|
+$110M |
| 5 |
Intuitive Surgical
ISRG
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 19.5% |
| 2 | Financials | 16.81% |
| 3 | Miscellaneous | 15.64% |
| 4 | Technology | 13.57% |
| 5 | Healthcare | 10.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
801
StandardAero Inc
SARO
$7.1B
| $188K | ﹤0.01% |
6,270
-50,455
| -89% | -$1.33M |
2024 Q4
6 quarters
|
|
802
BillionToOne Inc
BLLN
$4.94B
| $184K | ﹤0.01% |
+1,533
| New | +$140K |
2026 Q2
0 quarters
|
|
803
Fermi Inc
FRMI
$1.83B
| $183K | ﹤0.01% |
+20,023
| New | +$127K |
2026 Q2
0 quarters
|
|
804
Lucid Motors
LCID
$1.26B
| $183K | ﹤0.01% |
+27,332
| New | +$176K |
2026 Q2
0 quarters
|
|
805
Ameresco
AMRC
$1.05B
| $183K | ﹤0.01% |
6,623
+3,183
| +93% | +$92K |
2026 Q1
1 quarter
|
|
806
Core Natural Resources Inc
CNR
$4.35B
| $182K | ﹤0.01% |
+2,278
| New | +$202K |
2026 Q2
0 quarters
|
|
807
StepStone Group
STEP
$3.49B
| $182K | ﹤0.01% |
+4,404
| New | +$218K |
2026 Q2
0 quarters
|
|
808
Cadence Design Systems
CDNS
$89.8B
| $182K | ﹤0.01% |
484
-269,470
| -100% | -$94.4M |
2025 Q4
2 quarters
|
|
809
Iovance Biotherapeutics
IOVA
$6.62B
| $178K | ﹤0.01% |
+42,858
| New | +$163K |
2026 Q2
0 quarters
|
|
810
Pinterest
PINS
$13B
| $172K | ﹤0.01% |
+8,198
| New | +$165K |
2026 Q2
0 quarters
|
|
811
Essex Property Trust
ESS
$17.6B
| $170K | ﹤0.01% |
584
+583
| +58,300% | +$157K |
2026 Q1
1 quarter
|
|
812
iRhythm Holdings
IRTC
$3.74B
| $161K | ﹤0.01% |
+1,351
| New | +$157K |
2026 Q2
0 quarters
|
|
813
MP Materials
MP
$7.04B
| $160K | ﹤0.01% |
+2,853
| New | +$174K |
2026 Q2
0 quarters
|
|
814
Legend Biotech
LEGN
$3.62B
| $159K | ﹤0.01% |
+5,493
| New | +$148K |
2026 Q2
0 quarters
|
|
815
Calix
CALX
$2.3B
| $157K | ﹤0.01% |
4,210
+614
| +17% | +$25.8K |
2025 Q4
2 quarters
|
|
816
Harrow
HROW
$1.06B
| $157K | ﹤0.01% |
3,689
+3,686
| +122,867% | +$137K |
2026 Q1
1 quarter
|
|
817
Taboola.com
TBLA
$937M
| $155K | ﹤0.01% |
+31,037
| New | +$136K |
2026 Q2
0 quarters
|
|
818
Nektar Therapeutics
NKTR
$1.31B
| $155K | ﹤0.01% |
+2,217
| New | +$162K |
2026 Q2
0 quarters
|
|
819
Ichor Holdings
ICHR
$1.62B
| $152K | ﹤0.01% |
+1,351
| New | +$97.5K |
2026 Q2
0 quarters
|
|
820
Ingevity
NGVT
$2.43B
| $152K | ﹤0.01% |
+2,029
| New | +$146K |
2026 Q2
0 quarters
|
|
821
Coursera
COUR
$1.31B
| $151K | ﹤0.01% |
26,716
-19,919
| -43% | -$113K |
2025 Q4
2 quarters
|
|
822
CleanSpark
CLSK
$2.25B
| $149K | ﹤0.01% |
+10,257
| New | +$145K |
2026 Q2
0 quarters
|
|
823
Independence Realty Trust
IRT
$3.49B
| $146K | ﹤0.01% |
+8,749
| New | +$142K |
2026 Q2
0 quarters
|
|
824
Independent Bank
INDB
$3.85B
| $146K | ﹤0.01% |
+1,744
| New | +$138K |
2026 Q2
0 quarters
|
|
825
Avis
CAR
$3.48B
| $145K | ﹤0.01% |
+980
| New | +$216K |
2026 Q2
0 quarters
|
|
Similar funds
Freestone Grove Partners's Q2 2026 Portfolio in Review
As of Q2 2026, Freestone Grove Partners held 1,397 positions worth $15.6B, up 10% from $14.2B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Freestone Grove Partners's Q2 2026 filing shows 435 new, 253 increased, 266 reduced and 407 closed positions. Its largest new stake was Abbott: 1,372,846 shares worth $125M. The largest sale was Datadog, an estimated $128M.
By sector, the portfolio is most concentrated in Industrials at 20% of assets, up from 12% a quarter earlier, followed by Financials and Miscellaneous.
- Freestone Grove Partners's largest Q2 2026 buy was Abbott: 1,372,846 shares worth $125M.
- Freestone Grove Partners added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $311M increase.
- Freestone Grove Partners's biggest Q2 2026 reduction was Elastic, cutting an estimated $110M.
- Freestone Grove Partners fully exited Datadog in Q2 2026, selling an estimated $128M.
- Freestone Grove Partners's ten largest holdings make up 22% of its $15.6B portfolio in Q2 2026.
- Freestone Grove Partners opened 435 new positions and closed 407 in Q2 2026.
- Freestone Grove Partners's portfolio value rose 10% quarter-over-quarter to $15.6B.
Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.